Medico Remedies
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
27 05 2021 | Audited Results |
07 10 2021 | Increase in Authorised Capital & Bonus issue Inter alia, to transact the following business: 1. To consider increase in authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company; 2. To recommend and approve issue of Bonus shares to the equity shareholders of the Company; 3. To approve the proposal of Migration of Company from SME platform of BSE to Main Board of BSE Limited as well as on the Main Board of NSE Limited; 4. To approve the transactions to be entered into with the related parties of the Company; and 5. Any other business with the permission of the Chair. |
12 11 2021 | Half Yearly Results |
20 05 2022 | Audited Results |
12 08 2022 | Quarterly Results |
12 11 2022 | Quarterly Results |
02 02 2023 | Stock Split |
10 02 2023 | Quarterly Results |
11 05 2023 | Audited Results |
10 08 2023 | Quarterly Results |
09 11 2023 | Quarterly Results |
12 02 2024 | Quarterly Results |
12 11 2024 | Quarterly Results |
05 02 2025 | Quarterly Results |
No News data available